AKEBIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 2 2026 10:10:40 提供 NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

17 2 2026 10:52:51 提供 NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 2 2026 13:06:39 提供 NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

20 1 2026 09:46:18 提供 NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

13 1 2026 10:03:31 提供 NetDania Notify

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

12 1 2026 09:46:26 提供 NetDania Notify

Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook

12 1 2026 08:00:00 提供 Nasdaq GlobeNewswire

Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

06 1 2026 08:00:01 提供 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 1 2026 16:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

02 12 2025 10:42:52 提供 NetDania Notify

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 12 2025 16:05:00 提供 Nasdaq GlobeNewswire

Akebia Announces Establishment of Rare Kidney Disease Pipeline

01 12 2025 07:00:00 提供 Nasdaq GlobeNewswire

Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

24 11 2025 08:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: AKEBIA THERAPEUTICS INC. - COMMON STOCK

21 11 2025 09:45:05 提供 NetDania Notify

Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

10 11 2025 07:00:01 提供 Nasdaq GlobeNewswire

Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

06 11 2025 18:30:00 提供 Nasdaq GlobeNewswire

Akebia Therapeutics to Present at Upcoming Investor Conferences

04 11 2025 08:00:00 提供 Nasdaq GlobeNewswire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 11 2025 16:05:00 提供 Nasdaq GlobeNewswire

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

30 10 2025 08:00:01 提供 Nasdaq GlobeNewswire

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

28 10 2025 16:30:00 提供 Nasdaq GlobeNewswire